Qiagen NV Company Profile (NASDAQ:QGEN)

Analyst Ratings

Consensus Ratings for Qiagen NV (NASDAQ:QGEN) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $25.30 (5.60% downside)

Analysts' Ratings History for Qiagen NV (NASDAQ:QGEN)
Show:
DateFirmActionRatingPrice TargetActions
7/29/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2016DZ Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2016Commerzbank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/25/2016Piper Jaffray Cos.Reiterated RatingNeutral$23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Deutsche Bank AGReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Citigroup Inc.Lower Price TargetNeutral$28.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Barclays PLCLower Price TargetOverweight$28.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Cowen and CompanyBoost Price Target$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2015Stifel NicolausInitiated CoverageHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Goldman Sachs Group Inc.Lower Price Target$22.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2015WedbushLower Price TargetNeutral$21.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015MizuhoBoost Price TargetNeutral$23.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015Credit Suisse Group AGReiterated RatingNeutral$24.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2015Jefferies GroupBoost Price TargetHold$24.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015Bank of America Corp.DowngradeNeutral -> Underperform$26.00 -> $24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2014Leerink SwannBoost Price Target$24.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Qiagen NV (NASDAQ:QGEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
7/28/2016Q216$0.23$0.24$326.73 million$334.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2016Q116$0.19$0.19$295.76 million$298.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2016Q415$0.32$0.33$354.47 million$349.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q315$0.28$0.27$323.50 million$314.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015Q215$0.25$0.26$319.43 million$319.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115$0.22$0.22$304.60 million$298.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2015Q414$0.30$0.25$367.82 million$360.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2014Q3$0.27$0.27$337.00 million$336.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214$0.25$0.26$330.76 million$331.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114$0.22$0.22$317.09 million$317.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2014Q413$0.34$0.36$365.52 million$362.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313$0.25$0.28$320.37 million$323.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q213$0.24$0.27$311.75 million$316.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2013Q113$0.23$0.23$305.50 million$303.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2013Q412$0.31$0.34$327.80 million$346.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q312$0.24$0.26$303.79 million$304.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2012$0.25$0.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2012$0.21$0.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2012$0.28$0.31ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2011$0.22$0.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2011$0.23$0.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2011$0.21$0.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2011$0.25$0.26ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Qiagen NV (NASDAQ:QGEN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$0.19$0.25$0.22
Q2 20164$0.25$0.29$0.27
Q3 20164$0.27$0.30$0.28
Q4 20163$0.33$0.36$0.35
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Qiagen NV (NASDAQ:QGEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Qiagen NV (NASDAQ:QGEN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Qiagen NV (NASDAQ:QGEN)
DateHeadline
07/29/16 06:09 PMGermany stocks higher at close of trade; DAX up 0.61%
07/29/16 04:22 PMWhy Carbo Ceramics Inc. (CRR), Hewlett Packard Enterprise Co (HPE) and Qiagen NV (QGEN) Are 3 of Today’s Best Stocks - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips Earnings and takeover speculation made CRR, HPE and QGEN three of Friday's best stocks. The post Why Carbo Ceramics Inc. (CRR), Hewlett Packard Enterprise Co (HPE) and Qiagen NV (QGEN) Are 3 of Today’s Best Stocks appeared first on InvestorPlace.
07/29/16 03:34 PMWhy Carbo Ceramics Inc. (CRR), Hewlett Packard Enterprise Co (HPE) and Qiagen NV (QGEN) Are 3 of Today’s Best Stocks - InvestorPlaceInvestorPlace - Stock Market News, Stock Advice & Trading Tips Earnings and takeover speculation made CRR, HPE and QGEN three of Friday's best stocks. The post Why Carbo Ceramics Inc. (CRR), Hewlett Packard Enterprise Co (HPE) and Qiagen NV (QGEN) Are 3 of Today’s Best Stocks appeared first on InvestorPlace.
07/29/16 11:40 AMWhy Qiagen NV Jumped Higher Today - A strong second quarter for the healthcare and lab supply company boosted share prices.
07/29/16 10:26 AMQiagen (QGEN) Stock Soars as Q2 Results Surpass Expectations -
07/28/16 04:28 PMQiagen beats Street 2Q forecasts -
07/28/16 06:07 AMQ2 2016 Qiagen NV Earnings Release - 4:00 pm ET -
07/27/16 06:25 PMQiagen NV : launches “Digital NGS” solutions with unique Molecular Index Technology to reliably detect all genetic variation
07/27/16 03:18 PMQIAGEN launches “Digital NGS” solutions with unique Molecular Index Technology to reliably detect all genetic variation - [at noodls] - QIAseq Targeted NGS panels deliver highly sensitive, unbiased and accurate NGS insights Hilden, Germany, and Germantown, Maryland, July 27, 2016- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) ...
07/27/16 03:18 PMQIAGEN launches novel integrated system for collection, stabilization, transport, storage and isolation of circulating cell-free DNA - [at noodls] - PAXgene Blood ccfDNA enhances handling and workflow convenience for liquid biopsy applications in prenatal testing and cancer research Hilden, Germany, and Germantown, Maryland, July 27, 2016- QIAGEN N.V. ...
07/27/16 03:07 PMQIAGEN Launches "Digital NGS" Solutions with Unique Molecular Index Technology to Reliably Detect All Genetic Variation - [PR Newswire] - HILDEN, Germany and GERMANTOWN, Maryland, July 27, 2016 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of a comprehensive portfolio of novel QIAseq ...
07/24/16 10:05 AMIs $27 Price Target Attainable For Qiagen N.V. (NASDAQ:QGEN)? - Investor Newswire
07/24/16 10:05 AMIt's Earnings Time: What to Do with Qiagen NV (NASDAQ:QGEN) Stock - The Voice Registrar
07/20/16 06:53 PMShares Turning Downward: Qiagen NV (NASDAQ:QGEN) - TGP
07/19/16 04:01 AMQiagen NV Ord (NASDAQ:QGEN) Short Interest Increased By 14.75% - Press Telegraph
07/19/16 04:01 AMEarnings Focus and Crowd Sourced Sentiment Review for Qiagen N.V. (NASDAQ:QGEN) - TGP
07/18/16 02:07 PMQiagen sees call buying before earnings -
07/17/16 10:09 AMStrong Sell Calls For Qiagen N.V. (NASDAQ:QGEN) At 0 - Investor Newswire
07/14/16 09:38 AMQiagen NV : N.V. to Report Second Quarter and First Half of 2016 Results
07/14/16 04:14 AMQIAGEN N.V. to Report Second Quarter and First Half of 2016 Results - [PR Newswire] - VENLO, Netherlands, July 14, 2016 /PRNewswire/ -- QIAGEN N.V. (Nasdaq: QGEN) (Frankfurt: QIA) plans as previously announced to release its report on results for the second quarter and first half of 2016 ...
07/13/16 06:25 PMJohnston Asset Management Corp Decreased Stake in Qiagen Nv (NASDAQ:QGEN) by $50.48 Million as Shares ... - Consumer Eagle
07/12/16 06:17 PMQiagen N.V. (NASDAQ:QGEN) Wall Street Analyst Recommendation Outlook - Telanagana Press
07/12/16 10:24 AMQiagen NV Ord (NASDAQ:QGEN) Sellers Increased By 14.75% Their Shorts - Consumer Eagle
07/10/16 05:17 PMQiagen N.V. (NASDAQ:QGEN): Check on Company Stock Performance - Press Telegraph
07/10/16 05:17 PMAccounts Payable For Qiagen NV (NASDAQ:QGEN) Reach $38.93 - RealistInvestor.com
07/10/16 05:17 PMQiagen N.V. (NASDAQ:QGEN) Broker Price Targets For The Coming Week - Fiscal Standard
07/09/16 09:08 AMIs $27 Within Reach For Qiagen N.V. (NASDAQ:QGEN)? - Investor Newswire
07/09/16 09:08 AMQiagen N.V. (NASDAQ:QGEN) Current Analyst Ratings - Fiscal Standard
07/07/16 08:50 AMShares Declining and Worrying Investors: Qiagen NV (NASDAQ:QGEN) - Telanagana Press
07/07/16 08:50 AMCompany Stock Focus for Qiagen N.V. (NASDAQ:QGEN): Which Way Will Shares Head? - Press Telegraph
07/07/16 08:50 AMQiagen N.V. (QGEN) : Analyst Rating Update - Trade Calls
07/06/16 01:37 PMETF’s with exposure to QIAGEN NV : July 6, 2016 -
07/06/16 07:21 AMQIAGEN NV breached its 50 day moving average in a Bearish Manner : QGEN-US : July 6, 2016 -
07/06/16 02:31 AMExiqon A/S - CALL FOR REDEMPTION OF MINORITY SHAREHOLDERS IN EXIQON A/S UNDER SECTIONS 70 AND 72 OF THE DANISH COMPANIES ACT - [at noodls] - Exiqon A/S Company Announcement CALL FOR REDEMPTION OF MINORITY SHAREHOLDERS IN EXIQON A/S UNDER SECTIONS 70 AND 72 OF THE DANISH COMPANIES ACT Copenhagen, 2016-07-06 09:17 CEST (GLOBE NEWSWIRE) -- As ...
07/05/16 09:05 AMQIAGEN NV :QGEN-US: Earnings Analysis: For the six months ended December 31, 2015 : July 5, 2016 -
07/04/16 10:40 AMQiagen N.V. (NASDAQ:QGEN) Stock Focus and Earnings Glance - Telanagana Press
07/04/16 10:40 AMQiagen N.V. (NASDAQ:QGEN) Analyst Rating in Focus - Investor Newswire
07/03/16 10:11 AMQiagen N.V. (NASDAQ:QGEN) Expected to Reach Highs Of $27 - Investor Newswire
06/30/16 06:17 PMAnalyst Rating Update on Qiagen N.V. (QGEN) - TheFounders Daily
06/29/16 05:54 PMDekabank Deutsche Girozentrale Decreased Stake in Qiagen Nv (NASDAQ:QGEN) by $7.83 Million as Shares Declined - Engelwood Daily
06/28/16 05:57 PMQiagen N.V. (NASDAQ:QGEN) Updated Price Targets - FTSE News
06/28/16 05:57 PMQiagen N.V. (NASDAQ:QGEN): Reviewing Stock Performance - Press Telegraph
06/27/16 10:10 AMNext Weeks Broker Price Targets For Qiagen N.V. (NASDAQ:QGEN) - Fiscal Standard
06/26/16 05:04 PMStock Sentiment Review for :Qiagen N.V. (NASDAQ:QGEN) - Press Telegraph
06/25/16 05:27 PMStrong Sell Calls Recommendations For Qiagen N.V. (NASDAQ:QGEN) At 0 - Investor Newswire
06/25/16 05:27 PMQiagen N.V. (NASDAQ:QGEN): Update on Stock Performance - Press Telegraph
06/24/16 06:04 PMQiagen (QGEN) Completes Exiqon Tender Offer - StreetInsider.com
06/24/16 06:04 PMCan Qiagen NV (NASDAQ:QGEN) Meet Analysts Expectations? - Stocks Daily
06/24/16 07:33 AMQIAGEN NV breached its 50 day moving average in a Bullish Manner : QGEN-US : June 24, 2016 -
06/23/16 08:42 AMQiagen NV : Announces Successful Completion of Tender Offer for Shares in Exiqon

Social

About Qiagen NV

Qiagen NV logoQIAGEN N.V. (QIAGEN) is a holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Its bioinformatics solutions interpret data to provide actionable insights. Its automation platforms tie these together in molecular testing workflows-from Sample to Insight. Its Sample to Insight molecular technologies are applicable across a range of applications and customer classes through over 500 core consumable products, as well as instruments that automate the use of these products for sample preparation, analysis and interpretation. Its bioinformatics solutions connect laboratory workflows and process amounts of genomic data, enabling scientists or clinicians to decide on further action. It offers solutions in molecular diagnostics, applied testing, pharma and academia.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Research Services
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: QGEN
  • CUSIP: N7248210
Key Metrics:
  • Previous Close: $26.80
  • 50 Day Moving Average: $21.88
  • 200 Day Moving Average: $22.02
  • P/E Ratio: 51.54
  • P/E Growth: 2.20
  • Market Cap: $6.25B
  • Beta: 0.9
  • Current Year EPS Consensus Estimate: $1.08 EPS
  • Next Year EPS Consensus Estimate: $1.19 EPS
Additional Links:
Qiagen NV (NASDAQ:QGEN) Chart for Saturday, July, 30, 2016